A Covid-19 vaccine produced with the Russian Ministry of Defense completed Phase 2 trials leading First Deputy Minister of Defense Russian Tsalikov to state that the first domestic inoculation is fit for use now.
A second group of volunteers completed Phase 2 trials on 20 July, Monday, with everyone obtaining immunity against corona virus and feeling good, Tsalikov said in an interview published on 21 July, Tuesday with Argumentary I Fakty newspaper. He did not say when large-scale Phase 3 trials would take place, or when vaccine production could start.
The Ministry of Defense did not response to an immediate request for comment. The vaccine studies are ongoing, reported the Interfax news agency, quoting the Ministry of Health as are reference to the comment. “They are all getting ahead of themselves,” said Sergei Netesov, a former Vector director, a state-run virology center in Novosibirk that also focuses on inoculation. “The third process has not yet started, or even confirmed, so the reason they are in such a hurry is completely nonsensical.”
The army is creating a vaccine along with Moscow’s state-run Gamaleya Institute and the Russian Direct Investment Fund. Phase 3 trials, which will include many people in Russia, Saudi Arabia and the United Arab Emirates, are expected to begin in August. 3 and the vaccine delivery could begin as early as September, RDIF president Kirill Dmitriev said last week.
According to Dmitriev, Russia could receive 30 million doses domestically in 2020 and 170 million from abroad, with five countries showing interest in developing the vaccine and others ready to produce it.
Russia, which has the world’s fourth-most cases of corona virus, has intensified the development cycle and is funding production well before the vaccine is proven to operate, in the middle of a worldwide scramble to develop protections against the deadly pandemic that caused economic devastation. Phase 3 trials in developed economies typically take months to run to better understand the efficacy of a drug.